Score Breakdown
Offering Ability
42
Cash Runway
0
Float Risk
27
Warrant Exposure
30
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 49%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 89% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
model est. 55%
• 50-day avg $0.16 below $1 exchange minimum
📜 Warrant Exercise
model 15%
• Warrant overhang: 8.0% of shares outstanding
Market Data
Market Cap$2.80M
Shares Outstanding7.57M
Float5.85M
Cash$61.96M
Debt$11.82M
Short InterestN/A
Institutional Holdings
21.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest16.6K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2017-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ELOX Dilution Snapshot
Eloxx Pharmaceuticals, Inc. (ELOX) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 323,892.
- Recent SEC activity tracked for ELOX: xbrl on 2026-06-30; xbrl on 2017-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: